Return Styles: Pseud0ch, Terminal, Valhalla, NES, Geocities, Blue Moon. Entire thread

Stock investment tips.

Name: Sambo Charles !TzcAECrLis 2012-12-16 16:13

So certain events have occurred and I've decided to be a millionaire instead of a nurse, mainly to avoid any misunderstandings, since any misunderstandings would be big misunderstandings.

Anyway, I have my flaws, people misunderstand me, which I believe I have mentioned, perhaps I also am impatient and prefer to go my own way when learning things and end up out of the loop, not using the right terms and lingo, however on the plus side I have often been called a good judge of people/character and I believe I am quite competent and intelligent when I am committed.

What would be the absolute raw basics of investment then? I believe that I have the potential to become exceptional if I apply my finely honed reasoning skills to this task. I shall have my million in no time.

Name: idpurpose !eoPD6MpjJM 2013-02-25 18:14

Ohh i see you copied my post.

I have another stock to keep an eye on for Wednesday, which is more of a short term momentum play than CNAM. (which I consider a medium term hold at this point in time).

ANIK
Anika Therapeutics Inc.
http://finance.yahoo.com/q?s=ANIK&ql=1

Here is the deal with this company.

It is a small cap about ~150 million

Has about 40 million in cash.

Book value 1.38, so very value priced for a biotech company.

Primary product is an FDA approved drug ORTHOVISC, used for osteoarthritis, joints cartilage regeneration ect. They have a long lineup of other drugs and products as well, but the first one is their biggest cash cow. Their joint pain drug is the industry leader with no competition on the market yet, and doctors love it becasue it is expensive and has a big markup for them so they love to prescribe it.

The company earns about .74 cents a year in profit after all taxes and expense. Also has an acceptable peg ration ~.5 good earnings growth.

Why the stock is down now: One of their follow up drugs got FDA denied, their CFO stepped down, reason unknown, claimed personal. Last quarter earnings was a big disappointment came in at .12 cents instead of .17 expected.

The reason for the miss however was becasue they had to expand their facility to handle increased demand for their drugs, the expansion interrupted the orders in process. Company states all missed orders form q3 will be shipped q4. Company recently reiterated that they will beat or meet their guidance. Analysts expect .24 cents a share earnings. And they should get imo .23-.30. However these earnings are masking a lot of costs they are absorbing, and in fact this quarter will be a record breaking revenue and gross profit for them.

market is scared about their fda miss and earnings miss. On Wednesday they will put to doubt their earnings issues. And they are retrying to get back though the fda, their new drug was already approved in europe and asia.

The same thing happened in q1 after a miss the stock declined and after their next earnings report q2 where they beat, the stock rose over 3 dollars.

Stock trades around 10.50-10.70 now. Buying it around 10.50 would be ideal if you can get it that cheap. I am looking for a minimum 1 dollar rise in pps rise on Thursday. Range 11.50-13 in the days following the earnings report on Wednesday. I see almost no further downside risk beyond short term possible price pullback due to overall market conditions imo

Always do your own dd make your own decisions on what you can afford to risk.. good luck

Newer Posts
Don't change these.
Name: Email:
Entire Thread Thread List